// App-Quantinova.ai

S4281 2016 AHA : Baseline Risk Score and Interruption of Dual Antiplatelet Therapy Within One Year After Coronary Stents: The Dual Antiplatelet Therapy Study Results

Researchers

Presenter

  • Dean J Kereiakes

Principal Investigators

  • Robert W Yeh

  • Ada C Stefanescu Schmidt

  • P. Gabriel Steg

  • Hopital Bichat

  • Joseph M Massaro

  • Wen-Hua Hsieh

  • Laura Mauri

Medical Centers

  • Massachusetts General Hospital, Boston, MA

  • Assistance Publique, Hopitaux de Paris, Hopital Tenon, Paris, France

  • Christ Hosp Heart and Vascular Ctr, The Lindner Ctr for Res & Education, Cincinnati, OH

  • Brigham & Women's Hospital, Boston, MA

  • Beth Israel Deaconess Medical Center, Boston, MA

  • Harvard Clinical Rsch Institure, Boston, MA

  • Boston University School of Public Health, Boston, MA

Locations

  • United States

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Venous thrombosis

  • Coronary Artery Disease

Biomarkers

  • N/A

Drug/Treatment

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved